Formulary management of low molecular weight heparins.
2000
Low molecular weight heparins (LMWHs) are increasingly being utilised as anticoagulants in healthcare settings. These agents offer several advantages over standard unfractionated heparin. Indications for LMWHs include deep vein thrombosis and pulmonary embolism prophylaxis, deep vein thrombosis treatment, use in coronary procedures associated with a high risk for bleeding, and in acute coronary syndromes.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
147
References
13
Citations
NaN
KQI